Insulet Corp at Robert W Baird Global Healthcare Conference (Virtual) Transcript

Sep 15, 2021 / 06:00PM GMT
Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

All right. Good afternoon. I think we're all here now. So why don't we get started? My name is Jeff Johnson. I'm the senior medical technology analyst at Baird. And our next presentation this afternoon is from Insulet, a leader in the $3 billion global insulin pump market. With us today from Insulet, we're happy to have Chief Commercial Officer Bret Christensen; and VP of Investor Relations, Deb Gordon.

Bret, I think we'll just go into Q&A -- straight into Q&A, unless you have any fantastic overview you want to provide.

Bret Christensen - Insulet Corporation - Executive VP & Chief Commercial Officer

No. Jeff, thanks for having us. It's great to be here. I'm excited to talk about the business.

Questions and Answers:

Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Good. Good. Well, let's just jump right in. I want to talk -- I know
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot